Asano Akiko, Yamada Takeshi, Numata Atsushi, Doi Mitsunobu
Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan.
Acta Crystallogr C. 2003 Sep;59(Pt 9):o488-90. doi: 10.1107/s0108270103014495. Epub 2003 Aug 9.
The title compound, 1-cyclohexylmethyl-1-de(1-methylpropyl)ascidiacyclamide N,N-dimethylacetamide dihydrate, C(39)H(56)N(8)O(6)S(2) x C(4)H(9)NO x 2H(2)O, a cyclohexylalanine-incorporated ascidiacyclamide analogue ([Cha]ASC), shows a square form similar to natural ASC. On the other hand, CD (circular dichroism) spectra showed [Cha]ASC to have a folded structure in solution, making it the second known analogue to show a discrepancy between its crystal and solution structures. Moreover, the cytotoxicity of [Cha]ASC (ED(50) = 5.6 micro g ml(-1)) was approximately two times stronger than that of natural ASC or a related phenylalanine-incorporated analogue, viz. cyclo(-Phe-Oxz-D-Val-Thz-Ile-Oxz-D-Val-Thz-) ([Phe]ASC), and was confirmed to be associated with the square form. However, [Phe]ASC was previously shown to be folded in the crystal structure, which suggests that the difference between the aromatic and aliphatic rings affects the molecular folding of the ASC molecule.
标题化合物1-环己基甲基-1-去(1-甲基丙基)海鞘环肽酰胺N,N-二甲基乙酰胺二水合物,C(39)H(56)N(8)O(6)S(2)·C(4)H(9)NO·2H(2)O,一种掺入环己基丙氨酸的海鞘环肽酰胺类似物([Cha]ASC),呈现出与天然ASC相似的方形形态。另一方面,圆二色光谱显示[Cha]ASC在溶液中具有折叠结构,这使其成为已知的第二种在晶体结构和溶液结构之间存在差异的类似物。此外,[Cha]ASC的细胞毒性(ED(50)=5.6μg/ml)比天然ASC或一种相关的掺入苯丙氨酸的类似物,即环(-Phe-Oxz-D-Val-Thz-Ile-Oxz-D-Val-Thz-)([Phe]ASC)大约强两倍,并且证实与方形形态有关。然而,[Phe]ASC先前已被证明在晶体结构中是折叠的,这表明芳环和脂肪环之间的差异会影响ASC分子的分子折叠。